GIANNINI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 6.291
NA - Nord America 5.817
EU - Europa 3.528
SA - Sud America 348
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 307
OC - Oceania 11
Totale 16.634
Nazione #
US - Stati Uniti d'America 5.661
VN - Vietnam 1.829
SG - Singapore 1.518
CN - Cina 1.412
IT - Italia 1.316
GB - Regno Unito 562
HK - Hong Kong 473
DE - Germania 365
SE - Svezia 300
BR - Brasile 234
KR - Corea 218
BD - Bangladesh 214
IN - India 208
FR - Francia 204
NL - Olanda 155
RU - Federazione Russa 134
IE - Irlanda 109
FI - Finlandia 105
JP - Giappone 97
CA - Canada 92
SC - Seychelles 92
CI - Costa d'Avorio 77
JO - Giordania 50
ZA - Sudafrica 47
TG - Togo 45
ID - Indonesia 41
TH - Thailandia 40
AR - Argentina 39
PH - Filippine 34
AT - Austria 32
UA - Ucraina 32
PL - Polonia 29
MX - Messico 27
CH - Svizzera 26
ES - Italia 26
TR - Turchia 26
BG - Bulgaria 24
EE - Estonia 24
PK - Pakistan 24
EC - Ecuador 22
IQ - Iraq 22
TW - Taiwan 20
CO - Colombia 19
BE - Belgio 14
NG - Nigeria 13
UZ - Uzbekistan 13
CL - Cile 12
GR - Grecia 12
AU - Australia 11
HR - Croazia 10
JM - Giamaica 9
SA - Arabia Saudita 8
CR - Costa Rica 7
CZ - Repubblica Ceca 6
EG - Egitto 6
IR - Iran 6
KE - Kenya 6
LT - Lituania 6
MY - Malesia 6
PE - Perù 6
RS - Serbia 6
VE - Venezuela 6
MA - Marocco 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
PT - Portogallo 4
PY - Paraguay 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
PA - Panama 3
PS - Palestinian Territory 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
SI - Slovenia 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 16.288
Città #
Singapore 1.070
Ashburn 608
Ho Chi Minh City 464
Southend 460
Hefei 454
Hong Kong 434
Hanoi 409
Bologna 359
San Jose 335
Fairfield 325
Chandler 323
Ann Arbor 255
Seoul 200
Dong Ket 170
Los Angeles 162
Beijing 160
Houston 154
Council Bluffs 153
Seattle 150
Santa Clara 142
Woodbridge 141
Wilmington 134
Dallas 127
Boardman 126
Princeton 116
Dublin 109
New York 109
Redmond 106
Cambridge 104
Lauterbourg 91
Tokyo 87
Abidjan 77
Milan 70
Buffalo 67
Helsinki 66
Haiphong 57
Da Nang 55
Turin 55
Amman 49
Chicago 49
São Paulo 47
Lomé 45
Bengaluru 42
Florence 39
Nanjing 39
Rome 38
Redondo Beach 36
Berlin 35
Frankfurt am Main 34
Atlanta 33
Westminster 32
Padova 31
Munich 30
Orem 29
Shanghai 28
Amsterdam 27
Toronto 27
London 26
Lappeenranta 25
Biên Hòa 24
Jakarta 24
The Dalles 24
San Francisco 23
Sofia 23
Can Tho 22
Modena 22
Phoenix 22
Des Moines 21
Hải Dương 21
Guangzhou 20
Nuremberg 20
San Diego 20
Warsaw 20
Changsha 19
Shenyang 19
Vienna 19
Denver 18
Montreal 18
Quận Bình Thạnh 18
Tianjin 18
Ha Long 17
Johannesburg 17
Jacksonville 16
Parma 16
Rimini 16
Saint Petersburg 16
Thái Nguyên 16
Tongling 16
Hebei 15
Jinan 15
Naples 15
Redwood City 15
Thái Bình 15
Bangkok 14
Brooklyn 14
Brussels 14
Falkenstein 14
Paris 14
Bern 13
Genoa 13
Totale 9.961
Nome #
Anterior callosal angle correlates with gait impairment and fall risk in iNPH patients 626
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 361
The effects of cerebrospinal fluid tap-test on idiopathic normal pressure hydrocephalus: an inertial sensors based assessment 353
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 335
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 297
Evaluating gait and postural responses to subthalamic stimulation and levodopa: A prospective study using wearable technology 295
Pervasive and diffuse muscle activity during REM sleep and non-REM sleep characterises multiple system atrophy in comparison with Parkinson's disease 279
Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines 273
Analysis of Epigenetic Age Predictors in Pain-Related Conditions 269
The natural history of idiopathic autonomic failure: The IAF-BO cohort study 265
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment 265
AI-enhanced Wearables: Transforming Parkinson’s and Atypical Parkinsonism Diagnosis 238
Association between restless legs syndrome and migraine: a population-based study 233
Association of Cardiovascular Autonomic Failure With Progression and Phenoconversion in Isolated REM Sleep Behavior Disorder 232
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 231
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 228
Headache in epilepsy: prevalence and clinical features 226
Progression and prognosis in multiple system atrophy presenting with REM behavior disorder 226
A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study 224
A method for the synchronization of inertial sensor signals and local field potentials from deep brain stimulation systems 214
Stridor-related gray matter alterations in multiple system atrophy: A pilot study 211
REM Sleep Behaviour Disorder in Multiple System Atrophy: From Prodromal to Progression of Disease 210
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 204
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 200
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study 196
Comorbidity in Perimenstrual Migraine. 186
Early stridor onset and stridor treatment predict survival in 136 patients with MSA 186
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 178
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 178
Observing movement disorders: best practice proposal in the use of video recording in clinical practice 177
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies 177
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 175
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 173
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment 171
Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson’s Disease 169
Association between restless legs syndrome and hypertension: a preliminary population-based study in South Tyrol, Italy 169
Choroidal morphology and microvascular structure in eyes of patients with idiopathic normal pressure hydrocephalus before and after ventriculo-peritoneal shunt surgery 168
Gait apraxia evaluation in normal pressure hydrocephalus using inertial sensors. Clinical correlates, ventriculoperitoneal shunt outcomes, and tap-test predictive capacity 167
Normative values for the Instrumented Timed Up and Go test in Parkinsonian populations 167
The Degree of Cardiovascular Autonomic Dysfunction is not Different in GBA-Related and Idiopathic Parkinson's Disease Patients: A Case-Control Instrumental Evaluation 166
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 165
Risk of SARS-CoV-2 infection, hospitalization, and death for COVID-19 in people with Parkinson disease or parkinsonism over a 15-month period: A cohort study 164
Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD 164
Migraine and sleep disorders. 163
INPH and parkinsonism: A positive shunt response with a negative tap test 161
Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies 161
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 157
Prevalence, natural history and dynamic nature of chronic headache and medication overuse headache in Italy: The SPARTACUS study 157
Levodopa‐induced orthostatic hypotension in parkinsonism: A red flag of autonomic failure 156
The association between restless legs syndrome, cardiovascular and metabolic diseases: hypotheses and evidence from the literature 154
The treatment of sleep disorders in Parkinson's disease: From research to clinical practice 154
State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study 153
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 152
Cognitive Profile and Its Evolution in a Cohort of Multiple System Atrophy Patients 152
Open-aqueduct LOVA, LIAS, iNPH: a comparative clinical-radiological study exploring the "grey zone" between different forms of chronic adulthood hydrocephalus 151
Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study 151
Do anti-CGRP drugs have a role in migraine aura therapy? 151
A Brief History of Stereotactic Atlases: Their Evolution and Importance in Stereotactic Neurosurgery 150
Translation and linguistic validation of the Composite Autonomic Symptom Score COMPASS 31 148
The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study 144
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 141
Migraine: risk factor and comorbidity. 139
Migraine: The Hypersensitive Brain 137
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 136
In vivo assessment of the ocular biomechanical properties in patients with idiopathic normal pressure hydrocephalus 135
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 134
Local field potentials and motor performances modulation in response to stimulation and levodopa: a study on Parkinson's disease patients on chronic deep brain stimulation 133
Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: The impact of echo time and the potential of histogram analysis 132
Migraine and cardiovascular diseases. 132
Idiopathic intracranial hypertension without papilledema in refractory chronic daily headache 132
Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: A systematic review 131
Nociception and autonomic nervous system. 125
Case report: Bilateral double beta peak activity is influenced by stimulation, levodopa concentrations, and motor tasks, in a Parkinson's disease patient on chronic deep brain stimulation 120
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 119
null 119
A new synchronization method between inertial signals and local field potentials 118
How Accurate Is Frameless Fiducial—Free Deep Brain Stimulation? 111
Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism 111
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 106
RAB32 mutation in Parkinson's disease 104
Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts 103
Exploring Cardiovascular Autonomic Function before and after Chronic Deep Brain Stimulation in Parkinson's Disease 100
The Role of Simultaneous Medical Conditions in Idiopathic Normal Pressure Hydrocephalus 97
P063. Colloid cysts of the third ventricle: a case report 95
Comparison of Two α-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism 93
null 89
Correction to: Motor network pre-habilitation by low-frequency repetitive transcranial magnetic stimulation. A proof-of-concept 87
Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism 85
Identification of differentially expressed microRNAs in peripheral blood from Parkinson’s patients 83
White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study 82
Motor network pre-habilitation by low-frequency repetitive transcranial magnetic stimulation. A proof-of-concept 79
Open-Angle Glaucoma in Idiopathic Normal Pressure Hydrocephalus Before and After Ventriculo-Peritoneal Shunt Surgery: An Interventional Prospective Study 79
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 79
Anti-Ma2-associated limbic encephalitis presenting with transient epileptic amnesia 78
Tracheostomy is associated with increased survival in Multiple System Atrophy patients with stridor 78
Epigenetic DNA methylation changes in episodic and chronic migraine 73
PERIPAPILLARY ALTERATIONS IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS 71
Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease 68
Pervasive and diffuse muscle activity during rem and nrem sleep differentiates multiple system atrophy and Parkinson's disease 52
Quality of life and disability in pure autonomic failure: More than a prodromal synucleinopathy 45
Totale 16.537
Categoria #
all - tutte 45.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.248 0 48 84 97 124 68 58 117 74 158 244 176
2022/20231.387 134 173 56 141 143 112 52 83 248 46 145 54
2023/2024617 47 80 56 62 63 87 26 43 22 49 45 37
2024/20252.304 147 287 197 143 203 99 186 96 66 159 198 523
2025/20267.779 648 1.214 565 613 688 296 799 280 1.236 467 453 520
2026/2027766 558 208 0 0 0 0 0 0 0 0 0 0
Totale 16.634